UnitedHealth lawsuit proceeds as judge rejects motion to dismiss earnings manipulation claims
A federal judge allowed an investor lawsuit against UnitedHealth Group to continue, rejecting the company's request to throw out the case.
The suit alleges UnitedHealth inflated its 2024 earnings by about $3.3 billion to mask weakness in its Medicare Advantage segment.
While most of the allegations brought by CalPERS were dismissed as non-specific promotional statements, the core claim about earnings manipulation survives.
The decision means the case will move forward, potentially exposing UnitedHealth to further legal and investor scrutiny.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: UnitedHealth investor lawsuit moves forward on allegations it ‘manufactured earnings’ to hide declining profits”
read at STAT ↗
comments(0)
5-min edit window · permanent after that